Frontage Holdings Corporation (HKG:1521)
1.390
-0.080 (-5.44%)
Aug 22, 2025, 3:41 PM HKT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Laboratory Testing | 1.03B | Log In | Log In | Log In | Log In | Upgrade |
Laboratory Testing Growth | 6.83% | Log In | Log In | Log In | Log In | Upgrade |
Drug Development | 638.81M | Log In | Log In | Log In | Log In | Upgrade |
Drug Development Growth | -14.23% | Log In | Log In | Log In | Log In | Upgrade |
Drug Discovery | 243.65M | Log In | Log In | Log In | Log In | Upgrade |
Drug Discovery Growth | -6.98% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Product Development | 72.35M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Product Development Growth | 21.36% | Log In | Log In | Log In | Log In | Upgrade |
Preclinical Research | - | Log In | Log In | Log In | Log In | Upgrade |
Preclinical Research Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chemistry, Manufacturing and Controls | - | Log In | Log In | Log In | Log In | Upgrade |
Chemistry, Manufacturing and Controls Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chemistry | - | Log In | Log In | Log In | Log In | Upgrade |
Chemistry Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Early Stage Clinical/Bioequivalence | - | Log In | Log In | Log In | Log In | Upgrade |
Early Stage Clinical/Bioequivalence Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Drug Metabolism and Pharmacokinetics | - | Log In | Log In | Log In | Log In | Upgrade |
Drug Metabolism and Pharmacokinetics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Safety and Toxicology | - | Log In | Log In | Log In | Log In | Upgrade |
Safety and Toxicology Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
North America | 1.55B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | -0.76% | Log In | Log In | Log In | Log In | Upgrade |
China | 442.40M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -7.04% | Log In | Log In | Log In | Log In | Upgrade |